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Abstract In the present work, the RNA polymerase activity of
the human mitochondrial RNA polymerase mature protein
(h-mtRPOLm) is shown, and its molecular activity calculated
(2.1 þ 0.9 min31). An activity analysis of h-mtRPOLm and
deleted versions of it has demonstrated that the entire
recombinant protein is required for this activity. In addition,
h-mtRPOLm alone or in presence of the known mitochondrial
transcription factors (human mitochondrial transcription factor
A and/or human mitochondrial transcription termination factor)
is not able to initiate transcription from the specific human
mitochondrial promoters pointing to the existence of a human
mitochondrial transcription factor B-like protein. ß 2001 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Mitochondria are energy-producing organelles that contain
multiple copies of a genome, the mitochondrial DNA
(mtDNA) [1]. Human mtDNA transcription initiation sites
and promoter regions have been determined. The mitochon-
drial genome is transcribed from one heavy strand promoter
(HLP) with two initiation sites (H1 and H2) and one light
strand promoter (LSP) with one initiation site (L) [2,3]. This
genome contains binding regions for human mitochondrial
transcription factor A (h-mtTFA) [4] and human mitochon-
drial transcription termination factor (h-mTERF) [5]. In vitro
transcription initiation requires a mitochondrial RNA poly-
merase (h-mtRPOL) fraction and h-mtTFA [6]. However, in
yeast and frog the mtRPOL initiate speci¢c and accurate tran-
scription aided by other transcription factor, mtTFB [7,8].
Thus, whether human transcription initiation complex con-
sists of just h-mtRPOL and h-mtTFA or that it requires addi-
tional factors remains an important question [9].
The availability of human mitochondrial cDNAs encoding
mtRPOL [10], mtTFA [11] and mTERF [12] provide the pos-
sibility to study the transcription system in vitro. The present
work shows that h-mtRPOL, despite to an non-speci¢c RNA
polymerase activity, is not able to initiate speci¢c transcrip-
tion in vitro, and other factor(s) di¡erent from h-mtTFA and
h-mTERF must be necessary for initiation.
2. Materials and methods
2.1. Plasmid constructs and in vitro expression of proteins
The h-mtRPOL cDNA was subcloned in an in vitro expression
vector (pSPUTK, Stratagene), without the sequence that encodes
the mitochondrial target sequence, corresponding at the ¢rst 41 amino
acids [10]. The sequence encoding the mature protein was PCR-am-
pli¢ed using a forward primer matching the sequence of the desired 5P
end with a NcoI site (CC ATG GCC GCC AGC CCC CAG GAG
C-177, which produce a substitution of amino acids SS(+43) for MA),
and a reverse primer matching the sequence of the desired 3P end with
the SalI site (GTC GAC AAG GCT CAC GGG GTG TCA-3723).
The PCR fragments and pSPUTK vector were digested with NcoI and
SalI, ligated and ¢nally transformed in INVKFP cells (Invitrogen).
H-mtTFA cDNA was subcloned in a pSPUTK vector without the
¢rst 42 amino acids corresponding to the target peptide [11], using
the same strategy described above: forward primer, CC ATG GCT
GTC TTG GCA AGT TGT C-280, that produce the substitution of
SS (+44) for MA, and reverse primer, GTC GAC TTA ACA CTC
CTC AGC ACC-856. The construction of mature h-mTERF was
described previously [12]. The h-mtRPOL mutants lacking a segment
at the 5P and/or 3P-ends (vN406, vC100, vC400, vNC2 and vNC3)
were PCR-ampli¢ed from the plasmid containing the mature
h-mtRPOL by using the appropriate combination of primers match-
ing the sequence with the desired 5P and 3P-ends. The correct nucleo-
tide sequence of constructs was veri¢ed by chain terminator sequenc-
ing using Thermo Sequenase Terminator Cycle Sequencing Gel kit
and [K-33P]ddNTPs from Amersham. The corresponding encoded pro-
teins were expressed in the TNT SP6-coupled transcription^transla-
tion system (Promega) but in an uncoupled way. Thus, transcriptions
were carried out in 25-Wl reactions containing 40 mM Tris^HCl
(pH 8), 6 mM MgCl2, 2 mM spermidine, 50 Wg/ml BSA, 10 mM
DTT, 1 mM ATP, 1 mM UTP, 1 mM CTP, 1 mM GTP, 1 U/Wl
RNasin (Promega), 0.1 U/Wl SP6 RNA polymerase (Promega) and
1 Wg of linearized plasmid. After incubation at 37‡C for 2.5 h, 10 U
RNase-free DNase I (Promega) were added and incubated 15 min
more at the same temperature. The RNA was extracted, precipitated,
centrifuged and the pellet resuspended in 10 Wl of TE (10 mM Tris^
HCl (pH 8), 0.1 mM EDTA). Translations were performed following
the manufacturer’s protocol, but using 1 Wl RNA instead of DNA and
without SP6 RNA polymerase. When it was necessary to label pro-
teins, [35S]methionine (1000 Ci/mmol, Amersham) was used, and the
incorporation of radioactive label calculated.
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2.2. RNA polymerase activity
Non-speci¢c RNA polymerase activity was assayed with heat-dena-
tured salmon sperm DNA as template as described before [13], with
slight modi¢cations. The reactions contained 10 mM Tris^HCl (pH
8), 10 mM MgCl2, 1 mM DTT, 100 Wg/ml BSA, 10% (v/v) glycerol, 40
U RNasin, 50 Wg/ml heat-denatured salmon sperm DNA (Sigma),
1 mM ATP, 0.1 mM GTP, 0.1 mM CTP, 0.01 mM UTP and 1WM
[K-32P]UTP (400 Ci/mmol, Amersham). Incubation was at 30‡C for 30
min in presence of 10% (v/v) S-100 of a Tween-20 mitochondrial
lysate [14] or 10% (v/v) of in vitro synthesized protein. Puri¢cation
of synthesized RNA was carried out as described [14] and analyzed on
a 5% (w/v) polyacrylamide gel containing 7 M urea. The gel was dried
and exposed for autoradiography using an intensifying screen at
380‡C. To determine the molecular activity of h-mtRPOLm, the tran-
scription reactions were set up as described above. The reactions were
terminated at di¡erent times by trichloroacetic acid precipitation and
incorporated radioactive label was quantitated by scintillation count-
ing [13]. The h-mtRPOLm molecular activity was calculated from the
slopes of the curves that represents amount of UMP incorporated per
amount of h-mtRPOLm versus time. Those values were corrected for
reticulocyte lysate contribution. The molecular activity is de¢ned as
the number of molecules of UMP incorporated into acid-insoluble
product in 1 min at 30‡C per molecule of h-mtRPOLm.
Speci¢c RNA polymerase activity was carried out under the same
conditions as described above, but using EcoRI- and HindIII-digested
pTER plasmid [5] at 20 Wg/ml, as a template [14].
3. Results
3.1. In vitro expression of proteins known to be involved in
human mitochondrial transcription
The cDNAs of the h-mtRPOL, h-mtTFA and h-mTERF
subcloned in pSPUTK without the presequence were ex-
pressed in a rabbit reticulocyte lysate, to give mature proteins:
h-mtRPOLm (1189 aa and 13 4578 MW), h-mtTFAm (204 aa
and 24 426 MW) and h-mTERFm (342 aa and 39 187 MW).
Fig. 1 shows that the gel mobility of the expressed 35S-labeled
proteins is in agreement with their theoretical molecular
weight.
3.2. Transcription activity assay
In order to determine if the recombinant h-mtRPOLm was
active, the protein was assayed for RNA polymerase activity
using a non-selective template (denatured salmon sperm DNA
[13]) which does not require any additional factor. The
h-mtRPOLm was expressed in vitro in a rabbit reticulocyte
lysate system in an uncoupled way to avoid the presence of
the SP6 RNA polymerase in the activity assay. The products
from the activity assay were fractionated in a gel to discrim-
inate the contribution of nuclear-contaminant RNA polymer-
ase activity from the reticulocyte lysate. As shown in Fig. 2,
h-mtRPOLm, at a concentration of 1 nM produced RNA
synthesis of low and high molecular weight (lane 1). The syn-
thesis of the high molecular weight RNA was also obtained
when only reticulocyte lysate was tested (lane 2). This syn-
thesis was probably due to the presence of some nuclear
RNA polymerase in the reticulocyte lysate. On the other
hand, when the transcriptional activity was assayed using hu-
man mitochondrial lysate S-100 [14], only RNA synthesis of
low molecular weight was produced (lane 4). Therefore, the
low molecular weight RNA obtained with h-mtRPOLm was
due to its RNA polymerase activity, indicating that
h-mtRPOLm is a true RNA polymerase. The molecular ac-
tivity of h-mtRPOLm was calculated after correction for re-
ticulocyte lysate contribution. A value of 2.1 þ 0.9 min31
(average þ standard error of the mean of six independent ex-
periments) was obtained.
The speci¢c mitochondrial transcription activity was as-
sayed using pTER template that contains the natural pro-
moters and termination sequence of the human mtDNA [5]
(Fig. 3). When a human mitochondrial S-100 was used, a clear
RNA band from the L promoter was detected (lane 1), indi-
cating that all the proteins necessary for initiating mitochon-
drial transcription were present. The use of reticulocyte lysate
alone as a control to determine its interference in the assay
did not show any signal (lane 2). Afterwards, h-mtRPOLm
Fig. 1. SDS^PAGE analysis of the translation products synthesized
in presence of [35S]methionine.
Fig. 2. Non-speci¢c RNA polymerase activity. H-mtRPOLm (lane
1), S-100 lysate (lane 4) and two controls: rabbit reticulocyte lysate
(lane 2) or no protein (lane 3).
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was used in the speci¢c transcription assay. Although
h-mtRPOLm had RNA polymerase activity, by itself it was
unable to initiate mitochondrial transcription from its natural
promoters (lane 3). This result points to the necessity of other
factor(s) to initiate mitochondrial transcription. The DNA
binding activity of h-mtTFAm and h-mTERFm synthesized
in vitro, to their target sequences was con¢rmed by mobility
shift assay (data not shown). The addition of h-mtTFAm at a
concentration that has been shown previously to activate tran-
scription [15] (lane 4), h-mTERFm (lane 5) or both of them
(lane 6) to h-mtRPOLm produced none e¡ect in the initiation
of the transcription. In conclusion, a factor(s) di¡erent to
mtTFA and mTERF is required to promote speci¢city to
the promoter.
When the recombinant h-mtRPOLm was added to the as-
say with the mitochondrial S-100 (Fig. 3B, lane 2), the tran-
scription did not increase with respect to the mitochondrial
lysate alone (lane 1), suggesting that h-mtRPOLm is not a
limiting component of the transcription system.
3.3. h-mtRPOL activity domains
In order to gain insights into the role of di¡erent regions of
h-mtRPOL in its RNA polymerase activity, a series of dele-
tion mutants were derived from h-mtRPOLm (Fig. 4A). The
mutants were expressed in vitro in an uncoupled way (Fig.
4B) and then assayed for their non-speci¢c RNA polymerase
activity (Fig. 4C). The recombinant h-mtRPOLm had higher
activity that mitochondrial lysate S-100, while the mutants
vN406, vC100 and vC400 had just residual activity and
vNC2 and vNC3 had no activity, indicating that all regions
deleted in the di¡erent mutants are essential for RNA poly-
merase activity.
4. Discussion
In the present work, the recombinant mature protein,
h-mtRPOLm, was found to have non-speci¢c RNA polymer-
ase activity. Nevertheless, by itself it was not able to support
speci¢c transcription initiation from its natural human mito-
chondrial promoters. Addition of recombinant h-mtTFAm
and/or h-mTERFm was not able either to produce any level
of speci¢c initiation activity. This observation indicates that
another component(s) is necessary to confer this speci¢c ac-
tivity. The nature of this other component(s) is presently
under investigation in our laboratory.
As concerns the structure of h-mtRPOLm, the central ob-
servation made in the present work is that the entire recombi-
nant protein is required for the non-speci¢c RNA polymerase
activity.
The h-mtRPOL cDNA was identi¢ed by cyberscreening
and the predicted protein has a high identity with the car-
boxy-terminal half of the sequence of the yeast mtRPOL,
with a leader peptide that directs the protein into mitochon-
dria [10]. But remaining to be proved is the principal function
of this protein, its RNA polymerase activity. As shown in Fig.
2, the h-mtRPOLm synthesized in a mammalian system (rab-
bit reticulocyte lysate) has non-speci¢c activity, concluding
that h-mtRPOL is a true human mitochondrial RNA poly-
merase. A molecular activity of 2.1 þ 0.9 min31 was calculated
for h-mtRPOLm.
In the yeast Saccharomyces cerevisiae, mitochondrial tran-
scription initiation requires two essential components: a non-
speci¢c sc-mtRPOL that retains the core catalytic activity [16],
and a speci¢city factor required for promoter recognition, the
sc-mtTFB [7]. In addition, a sc-mtTFA is required for the
maintenance of mtDNA and stimulates 3^4-fold the transcrip-
tion in vitro in the presence of sc-mtRPOL and sc-mtTFB,
but is not able to substitute the sc-mtTFB protein [17]. As in
yeast, transcription of the Xenopus laevis mitochondrial ge-
nome is performed also by two separate components [18]:
the core xl-mtRPOL that exhibits non-speci¢c transcription
and a dissociatable factor required to confer speci¢city, the
xl-mtTFB, that has been puri¢ed but has yet to be cloned.
Furthermore, the xl-mtTFA, stimulates speci¢c transcription
in vitro by xl-mtRPOL and xl-mtTFB, but it is not required
for basal transcription [8].
In contrast to the cases described above, human mitochon-
drial transcription initiation in vitro from mitochondrial pro-
moters requires a mitochondrial RNA polymerase fraction,
which has not been puri¢ed to homogeneity, and other tran-
Fig. 3. Speci¢c mitochondrial RNA polymerase activity. A: S-100 (lane 1), rabbit reticulocyte lysate (lane 2), h-mtRPOLm alone (lane 3) or in
addition of h-mTERFm (lane 4) or h-mtTFAm (lane 5) or both together (lane 6). B: Transcription activity of S-100 in absence (lane 1) or
presence (lane 2) of h-mtRPOLm. IL, runo¡ transcripts from LSP; markers, pBR322 plasmid MspI-digested.
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scription factor, h-mtTFA, necessary for high levels of tran-
scription [6]. The h-mtTFA has the ability to wrap and un-
wind DNA in vitro, in an essentially non-speci¢c protein^
DNA complex [19]. It has been pointed that h-mtTFA could
be somehow able to provide the functions of both yeast tran-
scription factors, sc-mtTFA and sc-mtTFB, due to h-mtTFA
has an additional carboxy-terminal extension as well as a link-
er region between the two HMG box domains [19]. However,
xl-mtTFA and h-mtTFA contain highly conserved sequences
in these two regions that are not contained in yeast mtTFA [8]
and in X. laevis also exists mtTFB, indicating that h-mtTFA
may be not play the role of a mtTFB.
In this work it is presented an in vitro mitochondrial tran-
scription assays where the h-mtRPOL is not from a puri¢ed
fraction, but a recombinant protein. The expression of
h-mtRPOLm in an in vitro mammalian system guarantees
the presence of possible post-translational modi¢cations in
the recombinant protein, and the absence of any additional
mitochondrial transcription factor in the assays. Under these
conditions, h-mtRPOLm does not initiate transcription from
human mitochondrial promoters when used in a concentra-
tion previously shown to have non-speci¢c RNA polymerase
activity, and that this activity is even higher than that pro-
duced by the S-100 (see Figs. 3 and 4C). This initiation was
neither obtained when h-mtTFAm was added to the assay. It
was used at a stoichiometry of one molecule of h-mtTFA per
13 000 bp of linear template DNA (3.6 nM). High levels of
transcription have been observed when h-mtTFA was used at
stoichiometry between 23 000 and 2300 bp per molecule (0.7^7
nM) [15], a range that includes the concentration used in this
work. Under these conditions there is no speci¢c transcription
initiation, discarding the role of h-mtTFA as a component of
the basal transcription machinery.
Up to now, only another transcription factor involved in
human mitochondrial transcription has been cloned, the
h-mTERF [12]. In order to check if h-mTERF can play some
function in transcription initiation, the recombinant protein
was added to the transcription assays. The h-mtRPOLm was
unable to initiate transcription in presence of h-mTERFm
even when h-mtTFAm was included in the mixture. Under
this evidence the h-mTERFm is also discarded as a speci¢city
factor.
The possibility that the absence of speci¢c activity in the
assays is due to the inhibition by rabbit reticulocyte lysate was
discarded because S-100 was able to produce speci¢c activity
in its presence (Fig. 3B).
The data present in this work demonstrate that h-mtRPOL
itself has no speci¢city for its natural promoters, while
h-mtTFA and h-mTERF are not the speci¢city factor in
human mitochondrial transcription system. So, it must exits
other factor(s) that confers speci¢city to h-mtRPOL, that is, a
human equivalent mitochondrial transcription factor B
(h-mtTFB).
Finally, the analysis of the functional regions in h-mtRPOL
in this work was unable to de¢ne any protein truncations that
retained the RNA polymerase activity, indicating that multi-
ple regions encompassing the entire length of the protein are
involved in this activity.
Recently, the h-mtRPOL has been expressed in a non-mam-
malian expression system [20] and the puri¢ed protein was
active in RNA synthesis from poly(dA-dT) template but not
for the promoter-speci¢c activity in presence of h-mtTFA.
Fig. 4. Analysis of the h-mtRPOL mutants. A: Schematic represen-
tation of h-mtRPOLm and deleted constructs. B: SDS^PAGE anal-
ysis of the translation products. C: Non-speci¢c RNA polymerase
activity. The conserved peptide domains between h-mtRPOL and
the T3 RNA polymerase are indicated by black boxes and the num-
bers represent the amino acid positions [10] in A. The positions of
molecular mass markers are indicated in B.
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These authors concluded that additional factor(s) may be
needed, or that some mammalian-speci¢c modi¢cation is
missing in h-mtRPOL expressed in Escherichia coli. The re-
sults of the present paper point to the ¢rst possibility and
discard the second one, since the h-mtRPOLm was expressed
in a mammalian expression system.
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